skip to main content

News Archive

Date: 01/09/2017
As some national guidelines now recommend against routine prostate cancer screening, the overall rate of men receiving treatment for the disease declined 42 percent, a new study finds.
Date: 01/09/2017
Researchers at the University of Michigan have had initial success in mice using nanodiscs to deliver a customized therapeutic vaccine for the treatment of colon and melanoma cancer tumors.
Date: 01/05/2017
By developing a new mouse model to study a poorly understood protein, researchers uncovered its link to metaplastic breast cancer, opening the door to better understanding of this challenging breast cancer subtype.
Date: 12/21/2016
Nearly half of early stage breast cancer patients considered having double mastectomy and one in six received it – including many who were at low risk of developing a second breast cancer, a new study finds.
Date: 12/15/2016
Researchers found that patients whose oropharyngeal cancer recurred had higher levels of antibodies for two proteins, E6 and E7, which are found in HPV-fueled cancers. The finding suggests a potential blood-based marker that could predict when cancer is likely to return.
Date: 12/01/2016
Max S. Wicha, M.D., will receive the ninth annual Distinguished Lectureship in Breast Cancer Research from the American Association for Cancer Research. Wicha will present a special lecture as part of the 2016 San Antonio Breast Cancer Symposium.
Date: 11/30/2016
When faced with potentially life-threatening diseases such as cancer, people often seek information about the disease and support from peers.
Date: 11/02/2016
Researchers have identified a protein that helps ovarian cancer cells multiply and spread. By blocking it with a new antibody agent, they could slow the cancer’s growth and stop it from metastasizing.
Date: 10/24/2016
One of the earliest widespread applications of precision medicine in cancer care is helping patients and physicians decide whether chemotherapy is needed, a new study finds.
Date: 10/18/2016
A transcription factor known as Snail1 can act as a “molecular bypass” that diminishes the natural tumor suppressing action of a gene called p53 in breast cancer patients, a new study finds.